DCM Shriram Fine Chemicals
NSE: DSFCL · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock DCM Shriram Fine Chemicals's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
DCM Shriram Fine Chemicals manufactures high-value specialty chemicals, intermediates, and active ingredients primarily for the agrochemical, pharmaceutical, and performance polymer sectors. Operating as a wholly-owned subsidiary of DCM Shriram Limited, the business leverages advanced manufacturing facilities and strong research capabilities to provide custom synthesis and contract manufacturing services.
Business Model
The company generates revenue by supplying specialty chemicals and intermediates globally, backed by integration with its parent group's chlor-alkali and vinyl infrastructure for cost-competitive raw material sourcing.
Management Commentary
Management focuses on scaling operations through strategic capacity expansions to strengthen the company's position as a preferred global partner in the specialty chemical value chain.
Growth Outlook
Near-term growth is driven by strategic capacity expansions, increased demand from global agrochemical and pharmaceutical innovators, and enhanced cost competitiveness through backward integration.
Key Risks
- Raw Material Volatility. Fluctuations in key input costs can impact profit margins despite backward integration with the parent group.
- Regulatory and Environmental Compliance. Strict environmental standards and regulatory approvals for specialty chemical manufacturing can pose operational hurdles.
- Global Demand Cyclicality. Exposure to cyclical trends in the agrochemical and pharmaceutical sectors may affect order volumes.
Start your research today
Unlock AI insights, financials, peers and live data on DCM Shriram Fine Chemicals and 5,000+ companies — free.
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
DCM Shriram Fine ChemicalsDSFCL | ₹263 Cr | — | — | — | 1.8% | — | — | — |
Black Rose IndusBLACKROSE | ₹586 Cr | 19.65 | 13.25 | -0.2% | 12.5% | 17.8% | 23.9% | +10.3% |
Vipul OrganicsVIPULORG | ₹506 Cr | 55.50 | 28.24 | 16.8% | 10.4% | 9.0% | 13.0% | +26.1% |
Plastiblends India LimitedPLASTIBLEN | ₹487 Cr | 11.78 | 6.76 | 5.5% | 9.2% | 9.7% | 12.8% | +4.3% |
Agastya Energy and Infrastructure LimitedSANGINITA | ₹455 Cr | -19.81 | -83.28 | -23.2% | -3.2% | -18.0% | -14.1% | +581.9% |
Aarti SurfactantAARTISURF | ₹449 Cr | 22.93 | 9.64 | 25.2% | 6.1% | 7.7% | 12.4% | +7.3% |
As of Mar 2026
Financials
DCM Shriram Fine Chemicals
NSE: DSFCL · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock DCM Shriram Fine Chemicals's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
DCM Shriram Fine Chemicals manufactures high-value specialty chemicals, intermediates, and active ingredients primarily for the agrochemical, pharmaceutical, and performance polymer sectors. Operating as a wholly-owned subsidiary of DCM Shriram Limited, the business leverages advanced manufacturing facilities and strong research capabilities to provide custom synthesis and contract manufacturing services.
Business Model
The company generates revenue by supplying specialty chemicals and intermediates globally, backed by integration with its parent group's chlor-alkali and vinyl infrastructure for cost-competitive raw material sourcing.
Management Commentary
Management focuses on scaling operations through strategic capacity expansions to strengthen the company's position as a preferred global partner in the specialty chemical value chain.
Growth Outlook
Near-term growth is driven by strategic capacity expansions, increased demand from global agrochemical and pharmaceutical innovators, and enhanced cost competitiveness through backward integration.
Key Risks
- Raw Material Volatility. Fluctuations in key input costs can impact profit margins despite backward integration with the parent group.
- Regulatory and Environmental Compliance. Strict environmental standards and regulatory approvals for specialty chemical manufacturing can pose operational hurdles.
- Global Demand Cyclicality. Exposure to cyclical trends in the agrochemical and pharmaceutical sectors may affect order volumes.
Start your research today
Unlock AI insights, financials, peers and live data on DCM Shriram Fine Chemicals and 5,000+ companies — free.
Peers · Specialty Chemicals
As of Mar 2026